International Stem Cell Corp (OTCQX US:ISCO)

0.68
Delayed Data
As of Aug 11
 +0.05 / +7.94%
Today’s Change
0.27
Today|||52-Week Range
1.20
+17.24%
Year-to-Date
SECTOR
Commercial Services
INDUSTRY
Miscellaneous Commercial Services
MARKET CAP
$4.7M

Company Description

International Stem Cell Corp. is a clinical stage biotechnology company, which engages in the development of therapeutic and biomedical products. It operates through the following segments: Cosmetic Market, Biomedical Market, and Therapeutic Market. The Cosmetic Market segment develops, manufactures, and markets a cosmetic skin care products based on the company's proprietary parthenogenetic stem cell technology and targeted small molecule technology. The Biomedical Market segment involves in the development, manufacture, and commercialization of primary human cell research products. The Therapeutic Market segment focuses on the research and development of human parthenogenetic stem cells for the treatment of diseases of the central nervous system, liver diseases, and is currently conducting clinical trials for the treatment of Parkinson's disease. The company was founded by William B. Adams, Kenneth C. Aldrich, and Gregory S. Keller on August 17, 2001 and is headquartered in Carlsbad, CA.

Contact Information

International Stem Cell Corp.
5950 Priestly Drive
Carlsbad California 92008
P:(760) 940-6383
Investor Relations:

Employees

Shareholders

Individual stakeholders57.28%
Mutual fund holders--
Other institutional--

Top Executives

Andrey SemechkinCo-Chairman & Chief Executive Officer
Sophia GarnetteVP-Legal Affairs, Operations & Secretary
Russell KernDirector, Chief Scientific Officer & Executive VP